Abstract Objective: To assess the eect of topically applied isosorbide dinitrate (ISDN) ointment on super®cial hand veins preconstricted with phenylephrine. Methods: Using the hand vein compliance technique, venous diameter changes were measured in a doubleblind, randomised, placebo-controlled cross-over trial in 12 healthy volunteers. During preconstriction with phenylephrine, placebo or ISDN ointment was administered to assess the dilator eect of transdermal ISDN. Finally a single i.v. dose of nitroglycerine was administered into the hand vein to assess the maximal venous response to organic nitrovasodilators. Results: ISDN ointment (equivalent to 13.43.61 mg ISDN) caused a signi®cant dilator eect of 39.121.7% (meanSEM, P=0.02) which reached its maximum after 42.516.6 min. Maximum ISDN eects were inversely correlated with venous baseline diameter (r 2 =0.38, P=0.03) and independent of the amount of ointment applied or the extent of preconstriction (P>0.3). Conclusion: Similar to nitroglycerine, topical ISDN may relax super®cial hand veins within 60 min after application, suggesting that it might ease venepuncture particularly of small vessels. The large variability of the eect and the time to reach the eect, however, restrict its practical usefulness.
Introduction
Venepuncture is still the most frequently used invasive procedure in hospitalised patients. While invariably associated with emotional distress for the patient, this procedure may also challenge physicians and nursing sta ± particularly when the target veins are small and venous access is dicult. Because of the rich a-adrenergic innervation of super®cial veins, activation of the sympathetic nervous system may profoundly reduce venous diameter [1] and thus modulate the ease of i.v. insertion of needles. Several previous studies have suggested that nitroglycerine may facilitate venepuncture when applied topically. Nitroglycerine eciently reverses a-adrenergic venoconstriction [2, 3] by activation of the nitric oxide±cyclic guanosine monophosphate (NO-cGMP) cascade, a pathway which opposes a-adrenergic eects under physiological conditions. However, non-responders were frequent [4] , the optimum timing with respect to nitrate application has not been established [4, 5, 6, 7, 8, 9, 10] and the extent of venodilation has not been thoroughly investigated. The aim of this study was therefore to quantify venous relaxation over time using a double-blind, placebo-controlled design. Because no studies with organic nitrates other than nitroglycerine have been published, we chose to study the eect of topical isosorbide dinitrate (ISDN) which may also penetrate intact skin after transdermal application [11, 12, 13] .
Materials and methods

Individuals
Twelve healthy male non-smokers with a mean age of 25 years (22±32 years) and a mean body mass index of 23.3 kg/m 2 (21.8±25.8 kg/m 2 ) not taking any drugs were enrolled after full explanation of all study procedures and after they had given their written consent. The study was approved by the ethics committee of the University Hospital in Basel.
Study protocol
This was a single-dose, double-blind, two-arm, placebo-controlled, randomised cross-over study. The two study parts were separated by a wash-out phase of at least 1 week. Drug eects were assessed using the dorsal hand vein compliance technique [14] with slight modi®cations as described recently [15] . First normal saline solution at a constant rate of 0.25 ml/min was infused and the vein's baseline diameter was determined (de®ned as 100%). Then increasing dose rates of the full selective a 1 -agonist phenylephrine were administered (250±8000 ng/min) to constrict the vessel to approximately 30% of its initial diameter. Once a stable response was reached (de®ned as 0% relaxation), the ointment (ISDN; Isoket, Schwarz Pharma, Switzerland) or matching placebo was applied using a¯at-pointed spatula onto a skin area of approximately 1´1.5 cm. Diameter changes were then measured after 5, 10, 15, 20, 30, 40, 50 and 60 min. Finally, nitroglycerine (Perlinganit, Schwarz Pharma) was administered directly into the studied hand vein at a dose rate exerting maximum relaxation (1500 ng/min; [3] ) to assess the maximum local venous response to organic nitrates (measurements after 5 min and 8 min). The ISDN dose was determined by measuring the weight of the ointment applied.
To rule out systemic cardiovascular eects, blood pressure and heart rate were measured repeatedly throughout the study and 3 h after application of ointment, and the volunteers were asked to report any adverse event until study termination.
Data analysis
Data are expressed as meanSEM. Eects were compared using the paired student's t-test. Eects over time were compared using analysis of variance (ANOVA) for repeated measures. The relationship between hand vein diameter and ISDN eect was evaluated with linear regression analysis. A two-tailed P value of £ 0.05 was considered signi®cant. The data were performed using Statview for Macintosh (Version 4.5, Abacus Concept Inc.).
Results
The study drugs were well tolerated; mild headaches occurred in two volunteers approximately 30 min after application of ISDN ointment. Before and after administration of placebo heart rate was 53. Fig. 1 ) with a maximum of 39.121.7% (range 13±72%). Expressed in absolute diameter changes, maximum ISDN-induced venodilation was 0.230.12 mm and occurred after a lag time of 42.516.6 min (range 10±60 min). In 4 of the 12 individuals, ISDN relaxed the vein under investigation by at least 50%; in an additional 6 volunteers, at least 25% venodilation was reached (Fig. 2) . Maximum ISDN effects (expressed as percentage dilation) were inversely correlated with venous baseline diameter (r 2 =0.38, P=0.03; Fig. 2 ) and independent of the amount of ointment applied or the extent of preconstriction (P>0.3).
Nitroglycerine administered locally into the studied hand vein 60 min after ISDN or placebo application markedly relaxed the veins (placebo 68.35.3%; ISDN 66.04.4%; P=0.76).
Discussion
Access to the venous bed is a key requirement for both the diagnostic sampling of blood and the parenteral administration of drugs and¯uids. Venepuncture may be dicult because of vasospastic states that are common in patients with activation of the sympathetic nervous system such as those with volume losses, pain or emotional distress. Organic nitrates have been shown to reverse the eect of the two main sympathetic mediators of vasoconstriction, norepinephrine [2] and neuropeptide Y [16] , making them suitable candidates for venous relaxation under these conditions. Several controlled and uncontrolled trials with different formulations of nitroglycerine have consistently shown that topical nitroglycerine may relax super®cial veins when measured with subjective scores [5, 6, 7, 8] or when ease [5, 6, 8, 9, 10] or success of venepuncture were assessed [6] . Thus far, nitroglycerine is the only organic nitrate studied in this regard and its eects have been evaluated 15 [4] , 20 [6, 10] , 60 [7, 8, 9] and 120 min [5] after local application of ointments or tape. Whenever and however measured, the eects were highly variable and the optimum time for nitroglycerine application before venepuncture has not been established. Moreover, only one study attempted to assess venous diameter changes objectively using a slide gauge 15 min after application of ointment. In this trial, vasodilator responses were found in only 34% of the patients [4] suggesting that either non-responders were frequent, the dose was too small or that the duration of treatment and/or eect was too short. Since nitroglycerine is a rather ecient vasodilator, it is also conceivable that some patients were relaxed, venous tone therefore minimal and its pharmacological reversal thus not evident.
In this study we therefore attempted to de®ne the extent and time course of venous relaxation induced by topical nitrate application in super®cial veins that were all preconstricted with the a1-selective adrenoceptor agonist phenylephrine. Because tissue metabolism of organic nitrates is excessive, it appeared possible that the local metabolism of organic nitrates might modulate local eects. We thus chose not to study nitroglycerine because its rather short half-life relative to other organic nitrates was suspected to be one of the reasons for the substantial variability of eects reported in previous studies. At the same time, we attempted to evaluate whether topical ISDN, which was known to penetrate the skin as well, would be a useful alternative to relax super®cial veins.
This study revealed a signi®cant vasodilator eect of ISDN ointment con®rming the eectiveness of organic nitrates other than nitroglycerine. Indeed, administered at well below the therapeutic dose (<2% of regular dose), ISDN relaxed the vein on average by 39.121.7%. In the small vessels studied in this study, this resulted in an average absolute diameter change of 0.23 mm which almost equals the diameter dierence between a 19-G and a 21-G needle. The fact that in onethird of the individuals the vein was almost completely relaxed ( Fig. 2) indicates that important prerequisites for successful punctures are indeed met in a sizeable proportion of applications. Whether this translates into more successful venepunctures remains to be studied.
The primary endpoint of our study was ISDN-induced reversal of a-adrenergic preconstriction which was inversely correlated with the size of the exposed vein. Our study design was not suitable to elucidate the mechanism of this correlation. However, because all volunteers were exposed to almost identical ISDN doses irrespective of the vessel size, we believe that a likely explanation is that smaller veins were exposed to relatively higher amounts of drug.
While it may not be excluded that in some volunteers vasodilation will further increase beyond the observation period, eects occurring later than 1 h after administration were considered impractical in a clinical setting. The time course of ISDN-induced relaxation with rather late occurrence of the maximum eect renders this procedure not suitable for those states that require immediate intervention. Topical application of ISDN ointment may, however, be helpful in the many instances in which venepuncture can be planned (e.g. before regular surgery or in hospitalised patients) because the extent of eect observed in this study suggests that ISDN may indeed facilitate venepuncture particularly in smaller vessels which are more dicult to access. 
